Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HTGM - HTG Molecular Diagnostics Inc

Close
0.48
-0.120   -25.000%

Share volume: 0
Last Updated: Wed 14 Jun 2023 10:00:00 PM CEST
Analytical Laboratory Instrument Manufacturing : -3.83%

PREVIOUS CLOSE
CHG
CHG%
$0.60
-0.12
-20.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
29%
Profitability 33%
Dept financing 22%
Liquidity 75%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.48
P/E Ratio 
0.00
DAY RANGE
$0.48 - $0.48
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
2.214 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: John Lubniewski
Region: US
Website: https://www.htgmolecular.com/
Employees: 77
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Analytical Laboratory Instrument Manufacturing
Sector: Manufacturing

about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates sample and targeted library preparation for next-generation sequencing. additional information is available at www.htgmolecular.com.

Recent news